about
CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid LeukaemiaCCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to boneUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsProstate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T-cell subsets exposed to IL-2 versus IL-7/15CCN3 modulates bone turnover and is a novel regulator of skeletal metastasisBiomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.The CCN family proteins: modulators of bone development and novel targets in bone-associated tumorsBiomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems.CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression.
P2860
Q24598431-16CD347B-1B2A-40EE-BE1A-D4AD42DEBD50Q24609211-1E6C670F-6A85-400D-9DAB-2E3CAD98C8B6Q26829949-69CD6ADF-72AA-4AD7-AA25-FA8125674686Q28254386-67063D5C-A1CD-41CA-902B-D4E2E6CBEF43Q33688940-CE0D3BEE-5BB3-4775-AF01-8A924E58F347Q34381488-562AE5FD-3E5F-40AE-8248-2166D24D80ACQ36010515-B72927A6-622F-4939-B8CA-9A4AE2D69538Q36907188-6DAEA28A-090F-402F-931D-21AA048B69F1Q37557267-4E086115-D5CB-4DD2-8A6B-7DDCD8FDEBF1Q37740672-1ADCDC24-6883-40F9-B3ED-1EA820797EE5Q38615448-E8A989E5-4B4E-4010-8C35-65C856D5B23EQ38619155-8F846B33-D017-453B-90B4-8DF295CF73B3Q39174534-8266DCA8-86E2-4B30-B20D-D4174BEF9FBCQ47095922-D82BD899-57A4-46B9-B319-D0CEE9AD3D0F
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prognostic relevance of CCN3 in Ewing sarcoma
@ast
Prognostic relevance of CCN3 in Ewing sarcoma
@en
Prognostic relevance of CCN3 in Ewing sarcoma
@nl
type
label
Prognostic relevance of CCN3 in Ewing sarcoma
@ast
Prognostic relevance of CCN3 in Ewing sarcoma
@en
Prognostic relevance of CCN3 in Ewing sarcoma
@nl
prefLabel
Prognostic relevance of CCN3 in Ewing sarcoma
@ast
Prognostic relevance of CCN3 in Ewing sarcoma
@en
Prognostic relevance of CCN3 in Ewing sarcoma
@nl
P2093
P1433
P1476
Prognostic relevance of CCN3 in Ewing sarcoma
@en
P2093
Antonio Llombart-Bosch
Bernard Perbal
Diana Zambelli
Jose Antonio Lopez-Guerrero
Katia Scotlandi
Noureddine Lazar
P304
P356
10.1016/J.HUMPATH.2009.05.008
P407
P577
2009-10-01T00:00:00Z